keyword
https://read.qxmd.com/read/38363577/rna-interference-with-zilebesiran-for-mild-to-moderate-hypertension-the-kardia-1-randomized-clinical-trial
#21
JOURNAL ARTICLE
George L Bakris, Manish Saxena, Anil Gupta, Fadi Chalhoub, Jongtae Lee, Daniel Stiglitz, Nune Makarova, Nitender Goyal, Weinong Guo, Dion Zappe, Akshay S Desai
IMPORTANCE: Angiotensinogen is the most upstream precursor of the renin-angiotensin-aldosterone system, a key pathway in blood pressure (BP) regulation. Zilebesiran, an investigational RNA interference therapeutic, targets hepatic angiotensinogen synthesis. OBJECTIVE: To evaluate antihypertensive efficacy and safety of different zilebesiran dosing regimens. DESIGN, SETTING, AND PARTICIPANTS: This phase 2, randomized, double-blind, dose-ranging study of zilebesiran vs placebo was performed at 78 sites across 4 countries...
February 16, 2024: JAMA
https://read.qxmd.com/read/38362781/alternative-renin-angiotensin-system
#22
REVIEW
Michael Bader, U Muscha Steckelings, Natalia Alenina, Robson A S Santos, Carlos M Ferrario
The renin-angiotensin system is the most important peptide hormone system in the regulation of cardiovascular homeostasis. Its classical arm consists of the enzymes, renin, and angiotensin-converting enzyme, generating angiotensin II from angiotensinogen, which activates its AT1 receptor, thereby increasing blood pressure, retaining salt and water, and inducing cardiovascular hypertrophy and fibrosis. However, angiotensin II can also activate a second receptor, the AT2 receptor. Moreover, the removal of the C-terminal phenylalanine from angiotensin II by ACE2 (angiotensin-converting enzyme 2) yields angiotensin-(1-7), and this peptide interacts with its receptor Mas...
February 16, 2024: Hypertension
https://read.qxmd.com/read/38355818/comparison-of-the-effects-of-renal-denervation-at-early-or-advanced-stages-of-hypertension-on-cardiac-renal-and-adipose-tissue-pathology-in-dahl-salt-sensitive-rats
#23
JOURNAL ARTICLE
Kohzo Nagata, Kaito Tagami, Touko Okuzawa, Misaki Hayakawa, Akane Nomura, Tomo Nishimura, Katsuhide Ikeda, Kento Kitada, Shuhei Kobuchi, Yoshihide Fujisawa, Akira Nishiyama, Toyoaki Murohara
Renal denervation (RDN) has emerged as a novel therapy for drug-resistant hypertension. We here examined the effects of RDN at early versus advanced stages of hypertension on blood pressure and organ pathology in rats with salt-sensitive hypertension. Dahl salt-sensitive (DahlS) rats fed an 8% NaCl diet from 6 weeks of age were subjected to RDN (surgical ablation and application of 10% phenol in ethanol) or sham surgery at 7 (early stage) or 9 (advanced stage) weeks and were studied at 12 weeks. RDN at early or advanced stages resulted in a moderate lowering of blood pressure...
February 15, 2024: Hypertension Research: Official Journal of the Japanese Society of Hypertension
https://read.qxmd.com/read/38329697/anti-diabetic-potentials-of%C3%A2-lactobacillus-strains-by-modulating-gut-microbiota-structure-and-%C3%AE-cells-regeneration-in-the-pancreatic-islets-of-alloxan-induced-diabetic-rats
#24
JOURNAL ARTICLE
Manoj Kumar, Tharmar Muthurayar, Sukumaran Karthika, Santhalingam Gayathri, Perumal Varalakshmi, Balasubramaniem Ashokkumar
Diabetes mellitus, a most common endocrine disorder of glucose metabolism, has become a global epidemic and poses a serious public health threat with an increased socio-economic burden. Escalating incidence of diabetes is correlated with changes in lifestyle and food habits that cause gut microbiome dysbiosis and β-cells damage, which can be addressed with dietary interventions containing probiotics. Hence, the search for probiotics of human origin with anti-diabetic, anti-AGE, and anti-ACE potentials has gained renewed interest for the effective management of diabetes and its associated complications...
February 8, 2024: Probiotics and Antimicrobial Proteins
https://read.qxmd.com/read/38299956/-hypertension-what-s-new-in-2023
#25
JOURNAL ARTICLE
Gregoire Wuerzner, Belen Ponte, Antoinette Pechere-Bertschi
Highlights for 2023 include the confirmation of hypertension as a cardiovascular risk factor and the standard procedure for measuring blood pressure. Transdermal oestrogens do not appear to be associated with an increased risk of hypertension unlike oestrogen given orally. The usefulness of blood pressure measured in hospital in elderly patients and the risks of intensive treatment are reviewed. A new study suggests that we are not all equal when it comes to recommended treatments. Finally, RNA interference technology has enabled the synthesis of a new antihypertensive treatment administered every 6 months that inhibits the production of hepatic angiotensinogen with a good effect on blood pressure...
January 31, 2024: Revue Médicale Suisse
https://read.qxmd.com/read/38293826/transcriptomic-profiling-reveals-a-pronociceptive-role-for-angiotensin-ii-in-inflammatory-bowel-disease
#26
JOURNAL ARTICLE
James P Higham, Charity N Bhebhe, Rohit A Gupta, Michael M Tranter, Farah M Barakat, Harween Dogra, Natalie Bab, Eva Wozniak, Katie H Barker, Catherine H Wilson, Charles A Mein, Tim Raine, James J Cox, John N Wood, Nicholas M Croft, Paul D Wright, David C Bulmer
Visceral pain is a leading cause of morbidity in inflammatory bowel disease (IBD), contributing significantly to reduced quality of life. Currently available analgesics often lack efficacy or have intolerable side effects, driving the need for a more complete understanding of the mechanisms causing pain. Whole transcriptome gene expression analysis was performed by bulk RNA sequencing of colonic biopsies from patients with ulcerative colitis (UC) and Crohn disease (CD) reporting abdominal pain and compared with noninflamed control biopsies...
January 29, 2024: Pain
https://read.qxmd.com/read/38293823/egcg-oxidation-derived-polymers-induce-apoptosis-in-digestive-tract-cancer-cells-via-regulating-the-renin-angiotensin-system
#27
JOURNAL ARTICLE
Mingchuan Yang, Ximing Wu, Yufeng He, Xiuli Li, Lumin Yang, Tingting Song, Fuming Wang, Chung S Yang, Jinsong Zhang
Green tea polyphenol (-)-Epigallocatechin-3-gallate (EGCG) has been well studied for its biological activities in the prevention of chronic diseases. However, the biological activities of EGCG oxidation-derived polymers remain unclear. Previously, we found that these polymers accumulated in intraperitoneal tissues after intraperitoneal injection and gained an advantage over native EGCG in increasing insulin sensitivity via regulating the renin-angiotensin system (RAS) in type 2 diabetic mice. The present study determined the pro-apoptosis activities and anticancer mechanisms of the EGCG oxidation-derived polymer preparation (the >10 kDa EGCG polymers) in digestive tract cancer cells...
January 31, 2024: Food & Function
https://read.qxmd.com/read/38289730/chronic-lithium-toxicity-in-old-age-patients-taking-angiotensin-receptor-blocker-a-case-report
#28
JOURNAL ARTICLE
Asim Pandey, Kunjan Khanal, Anushree Jha, Prava Basnet, Dipesh Bhattarai
UNLABELLED: Chronic lithium toxicity is a potentially serious side effect on patients taking lithium for a prolonged period with the diagnosis of mood disorders. The toxicity is even higher in patients taking drugs that interfere with the metabolism of lithium like angiotensin receptor blockers and in older patients with reduced kidney function. In this report, we present the case of a 62-year-old woman who presented to the emergency department with symptoms including loose stools, generalised body weakness, slurred speech, coarse hand tremors, and dystonia persisting for fifteen days...
November 1, 2023: JNMA; Journal of the Nepal Medical Association
https://read.qxmd.com/read/38265173/correlation-of-single-nucleotide-polymorphisms-in-the-agt-gene-with-susceptibility-to-systemic-lupus-erythematosus-in-northeast-china
#29
JOURNAL ARTICLE
Huitao Wu, Xuan Zhang, Guiling Lin, Qi Zhang, Ziman He, Zhe Wang, Wenlu Xu, Xiyu Yin, Linglan Su, Yanping Zhuang, Aimin Gong
To investigate the correlation between susceptibility to systemic lupus erythematosus (SLE) and single nucleotide polymorphisms (SNPs) rs699, rs4762 and rs1926723 in the AGT gene in the population of Northeast China, while also introducing a new method for early detection of SLE. A total of 856 cases of SLE patients and healthy volunteers who attended the First Affiliated Hospital of Harbin Medical University from January 2020 to December 2022 were recruited. Clinical information and biood samples were collected from particpants in this study...
January 24, 2024: International Journal of Immunogenetics
https://read.qxmd.com/read/38222129/review-of-teratogenic-effects-of-leflunomide-accutane-thalidomide-warfarin-tetracycline-and-angiotensin-converting-enzyme-inhibitors
#30
REVIEW
Raegan B Abadie, Camryn L Keller, Nicholas T Jones, Erin L Mayeux, Rachel J Klapper, Lillian Anderson, Adam M Kaye, Shahab Ahmadzadeh, Giustino Varrassi, Sahar Shekoohi, Alan D Kaye
Teratogenic agents have been shown to have drastic and detrimental effects on fetuses if exposed to the agent during uterine life. The most sensitive time for a developing fetus is during the first trimester, and teratogenic exposure during this time can lead to severe deformities in the fetus. The Food and Drug Administration has categorized teratogenic agents based on the severity of their effect on the fetus; these categories include A, B, C, D, and X. Category A is the safest, with the most dangerous, and highly contraindicated in pregnant patients being Category X...
December 2023: Curēus
https://read.qxmd.com/read/38203807/urinary-angiotensinogen-displays-sexual-dimorphism-in-non-diabetic-humans-and-mice-with-overweight
#31
JOURNAL ARTICLE
Alexis A Gonzalez, Bruna Visniauskas, Virginia Reverte, Ventaka N Sure, Zoe Vallotton, Bryan S Torres, Marco A Acosta, Mahlet Zemedkun, Prasad V Katakam, Minolfa C Prieto
Increased body weight (BW) induces inappropriate renin-angiotensin system (RAS) activation. The activation of the intrarenal RAS is associated with increased urinary angiotensinogen (uAGT), blood pressure (BP), and kidney damage. Here, we examined uAGT excretion levels in young non-diabetic human subjects with overweight (OW) and non-diabetic mice with high-fat diet (HFD)-induced OW. Human subjects (women and men; 20-28 years old) included two groups: (a) overweight (OW, n = 17, BMI ≥ 25); and (b) controls (normal weight (NW; n = 26, BMI ≤ 25)...
January 4, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38203499/molecular-therapies-in-cardiovascular-diseases-small-interfering-rna-in-atherosclerosis-heart-failure-and-hypertension
#32
REVIEW
Riccardo Sarzani, Francesco Spannella, Chiara Di Pentima, Federico Giulietti, Matteo Landolfo, Massimiliano Allevi
Small interfering RNA (siRNA) represents a novel, fascinating therapeutic strategy that allows for selective reduction in the production of a specific protein through RNA interference. In the cardiovascular (CV) field, several siRNAs have been developed in the last decade. Inclisiran has been shown to significantly reduce low-density lipoprotein cholesterol (LDL-C) circulating levels with a reassuring safety profile, also in older patients, by hampering proprotein convertase subtilisin/kexin type 9 (PCSK9) production...
December 26, 2023: International Journal of Molecular Sciences
https://read.qxmd.com/read/38166133/impact-of-the-gene-polymorphisms-in-the-renin-angiotensin-system-on-cardiomyopathy-risk-a-meta-analysis
#33
JOURNAL ARTICLE
Xiaoxiao Jia, Liping Meng, Weiliang Tang, Liping Sun, Fang Peng, Peng Zhang
Due to the inconsistent findings from various studies, the role of gene polymorphisms in the renin-angiotensin system in influencing the development of cardiomyopathy remains unclear. In this study, we conducted a systematic review and meta-analysis to summarize the findings regarding the impact of angiotensin converting enzyme (ACE) I/D, angiotensinogen (AGT) M235T, and angiotensin II Type 1 receptor (AGTR1) A1166C gene polymorphisms in patients with cardiomyopathy. We performed a comprehensive search of several electronic databases, including PubMed, Embase, the Cochrane Library, and Web of Science, covering articles published from the time of database creation to April 17, 2023...
2024: PloS One
https://read.qxmd.com/read/38161127/a-longitudinal-study-on-the-effect-of-obesity-upon-circulating-renin-angiotensin-system-in-normal-pregnancy
#34
JOURNAL ARTICLE
Stella Bernardi, Federica Tonon, Moira Barbieri, Giulia Zamagni, Roberto Nuredini, Laura Perer, Sarah Comar, Barbara Toffoli, Luca Ronfani, Giuseppe Ricci, Bruno Fabris, Tamara Stampalija
BACKGROUND AND AIMS: Obesity is the most common health issue in women of reproductive age, which profoundly affects maternal-fetal health. Despite progress in understanding key inflammatory and metabolic changes, the pathogenesis of the cardiovascular phenotype of obese pregnant women remains to be fully understood. This study aimed at: (i) evaluating the changes of the renin-angiotensin system (RAS) throughout pregnancy in obese vs normal weight (control) women, and (ii) evaluating the presence of any associations between maternal hemodynamic status and RAS changes...
October 28, 2023: Nutrition, Metabolism, and Cardiovascular Diseases: NMCD
https://read.qxmd.com/read/38156515/obese-male-mice-exposed-to-early-life-stress-display-sympathetic-activation-and-hypertension-independent-of-circulating-angiotensin-ii
#35
JOURNAL ARTICLE
Carolina Dalmasso, Nermin S Ahmed, Sundus Ghuneim, Cole Cincinelli, Jaqueline R Leachman, Jorge F Giani, Lisa Cassis, Analia S Loria
BACKGROUND: We have previously reported that male mice exposed to maternal separation and early weaning (MSEW), a model of early life stress, show sympathetic activation and increased blood pressure in response to a chronic high-fat diet. The goal of this study was to investigate the contribution of the renin-angiotensin-aldosterone system to the mechanism by which MSEW increases blood pressure and vasomotor sympathetic tone in obese male mice. METHODS AND RESULTS: Mice were exposed to MSEW during postnatal life...
December 29, 2023: Journal of the American Heart Association
https://read.qxmd.com/read/38154557/glomerular-transcriptomics-predicts-long-term-outcome-and-identifies-therapeutic-strategies-for-patients-with-assumed-benign-iga-nephropathy
#36
JOURNAL ARTICLE
Mariell Rivedal, Håvard Mikkelsen, Hans-Peter Marti, Lili Liu, Krzysztof Kiryluk, Thomas Knoop, Rune Bjørneklett, Yngvar Lunde Haaskjold, Jessica Furriol, Sabine Leh, Flavia Paunas, Janka Bábíčková, Andreas Scherer, Camille Serre, Oystein Eikrem, Philipp Strauss
Some patients diagnosed with benign IgA nephropathy (IgAN) develop a progressive clinical course, not predictable by known clinical or histopathological parameters. To assess if gene expression can differentiate between progressors and non-progressors with assumed benign IgAN, we tested microdissected glomeruli from archival kidney biopsy sections from adult patients with stable clinical remission (21 non-progressors) or from 15 patients that had undergone clinical progression within a 25-year time frame. Based on 1 240 differentially expressed genes from patients with suitable sequencing results, we identified eight IgAN progressor and nine non-progressor genes using a two-component classifier...
December 26, 2023: Kidney International
https://read.qxmd.com/read/38130930/differentially-expressed-genes-in-orbital-adipose-connective-tissue-of-thyroid-associated-orbitopathy
#37
JOURNAL ARTICLE
Yan Wang, Yanqiu Liu, Jiping Cai, Tianyi Zong, Ziyin Zhang, Tianhua Xie, Tong Mu, Meili Wu, Qian Yang, Yangningzhi Wang, Xiaolu Wang, Yong Yao
BACKGROUND: Thyroid-associated orbitopathy (TAO) is a disease associated with autoimmune thyroid disorders and it can lead to proptosis, diplopia, and vision-threatening compressive optic neuropathy. To comprehensively understand the molecular mechanisms underlying orbital adipogenesis in TAO, we characterize the intrinsic molecular properties of orbital adipose/connective tissue from patients with TAO and control individuals. METHODS: RNA sequencing analysis (RNA-seq) was performed to measure the gene expression of orbital adipose/connective tissues of TAO patients...
2023: PeerJ
https://read.qxmd.com/read/38092813/the-role-of-captopril-in-leukotriene-deficient-type-1-diabetic-mice
#38
JOURNAL ARTICLE
João Pedro Tôrres Guimarães, Luiz A D Queiroz, Kalhara R Menikdiwela, Nayara Pereira, Theresa Ramalho, Sonia Jancar, Naima Moustaid-Moussa, Joilson O Martins
T1D can be associated with metabolic disorders and several impaired pathways, including insulin signaling, and development of insulin resistance through the renin-angiotensin system (RAS). The main precursor of RAS is angiotensinogen (Agt) and this system is often linked to autophagy dysregulation. Dysregulated autophagy has been described in T1D and linked to impairments in both glucose metabolism, and leukotrienes (LTs) production. Here, we have investigated the role of RAS and LTs in both muscle and liver from T1D mice, and its effects on insulin and autophagy pathways...
December 13, 2023: Scientific Reports
https://read.qxmd.com/read/38077007/epigenetic-small-molecule-screen-for-inhibition-and-reversal-of-acinar-ductal-metaplasia-in-mouse-pancreatic-organoids
#39
Kalina R Atanasova, Corey M Perkins, Ranjala Ratnayake, Jinmai Jiang, Qi-Yin Chen, Thomas D Schmittgen, Hendrik Luesch
BACKGROUND: Acinar ductal metaplasia (ADM) is among the earliest initiating events in pancreatic ductal adenocarcinoma (PDAC) development. METHODS: We developed a novel morphology-based screen using organoids from wildtype and p48 Cre/+ (Cre) mice to discover epigenetic modulators that inhibit or reverse pancreatic ADM more effectively than the broad-spectrum HDAC inhibitor trichostatin A (TSA). RESULTS: Of the 144 compounds screened, nine hits and two additional natural product HDAC inhibitors were validated by dose-response analysis...
November 27, 2023: bioRxiv
https://read.qxmd.com/read/38045440/machine-learning-based-biomarker-profile-derived-from-4210-serially-measured-proteins-predicts-clinical-outcome-of-patients-with-heart-failure
#40
JOURNAL ARTICLE
Marie de Bakker, Teun B Petersen, Anja J Rueten-Budde, K Martijn Akkerhuis, Victor A Umans, Jasper J Brugts, Tjeerd Germans, Marcel J T Reinders, Peter D Katsikis, Peter J van der Spek, Rachel Ostroff, Ruicong She, David Lanfear, Folkert W Asselbergs, Eric Boersma, Dimitris Rizopoulos, Isabella Kardys
AIMS: Risk assessment tools are needed for timely identification of patients with heart failure (HF) with reduced ejection fraction (HFrEF) who are at high risk of adverse events. In this study, we aim to derive a small set out of 4210 repeatedly measured proteins, which, along with clinical characteristics and established biomarkers, carry optimal prognostic capacity for adverse events, in patients with HFrEF. METHODS AND RESULTS: In 382 patients, we performed repeated blood sampling (median follow-up: 2...
December 2023: European heart journal. Digital health
keyword
keyword
46817
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.